Elizabeth A. Barrett insider trades

Open-market stock purchases and sales by Elizabeth A. Barrett, Director at Allogene Therapeutics, Inc, from SEC Form 4 filings since Jan 3, 2018.

Track record: 100% of 4 scored buys are up 5% or more since purchase, averaging +44%.

Recent trades

DateStockTradeValue
Jun 18, 2026ALLO Allogene Therapeutics, IncBought (not open market)—
Jan 31, 2026URGN UroGen Pharma LtdBought (not open market)—

Companies traded

  • ALLO Allogene Therapeutics, Inc: other filings, last Jun 18, 2026
  • URGN UroGen Pharma Ltd: 4 buys, 3 sales, last Jan 31, 2026
  • SAGE Sage Therapeutics, Inc: other filings, last Jul 31, 2025

Get free alerts when Elizabeth A. Barrett files a new trade →